MetaCap

Evotec (EVO) vs Helus Pharma (HELP)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Helus Pharma (HELP) has outperformed Evotec (EVO) over the past year, gaining 9.3% versus a loss of 55.6%. Over five years, HELP leads with a -88.1% price change compared with -94.4% for EVO. Helus Pharma is the larger company by market cap ($487.7 million vs $469.1 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

EVO-55.56%HELP+9.30%
+161%+48%-66%
Nov 21, 20251 yearNov 20, 2026
EVO-94.42%HELP-90.14%
+5%-47%-99%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

EVO versus HELP key metrics
MetricEVOHELP
Share price$1.32$6.11
Market cap$469.11M$487.68M
1-day change-8.97%-9.88%
YTD return-57.14%-25.31%
1-year return-55.56%+9.30%
5-year return-94.44%-88.09%
EPS (TTM)$-0.59$-4.25
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$3.87$15.15
52-week low$1.32$3.76
Distance from 52-week high-65.89%-59.67%
Analyst consensusbuynone
Avg. price target upside+237.12%+564.81%
Average volume109.16K1.83M
Shares outstanding355.39M79.81M
Employees4,379100
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • HELP has outperformed EVO by 64.9 percentage points over the past year.

About Evotec

EVO stock →

Evotec SE operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally. It operates in two segments, Shared R&D and Just – Evotec Biologics.

Health Care · Biotechnology: Pharmaceutical Preparations · 4,379 employees

About Helus Pharma

HELP stock →

Helus Pharma Inc. operates as a clinical stage pharmaceutical company that focuses on developing therapies to treat psychiatric and neurological conditions.

Health Care · Biotechnology: Pharmaceutical Preparations · 100 employees

EVO vs HELP FAQ

Which is bigger, Evotec or Helus Pharma?

Helus Pharma (HELP) is larger, with a market capitalization of $487.68M compared with $469.11M for Evotec (EVO).

Which stock has performed better over the past year, EVO or HELP?

HELP returned +9.30% over the past 12 months, compared with -55.56% for EVO (price return, excluding dividends). Past performance does not predict future results.

Are Evotec and Helus Pharma in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons